Clinical Trials, FDA, Therapeutics Corey Hubbard Clinical Trials, FDA, Therapeutics Corey Hubbard

Breathing Easier? BiomX's Revolutionary Phage Therapy for Cystic Fibrosis Enters Advanced Trials

Cystic Fibrosis (CF) is a complex genetic disease that severely impacts multiple organs, particularly the lungs. For many CF patients, the persistent presence of stubborn bacterial infections in the lungs poses a life-threatening challenge. Among these, chronic pulmonary infections caused by Pseudomonas aeruginosa

Read More